Evaluation of the results revealed pronounced clinical manifestations on the dorsal skin of DNCB-challenged mice, characterized by erythema, edema, scarring, dryness, excoriation, and hemorrhage (Fig. 2A), accompanied by elevated dermatitis scores and serum levels of IgE (Fig. 2B and C). The gene discussed is IGHE; the disease is skin disorder.